Русский

Pharmaceutical Industry Information Portal

HomeTagsAlzheimer disease

All posts by tag

Alzheimer disease

Alzheimer’s disease is a progressive neurologic disorder that causes the brain to shrink (atrophy) and brain cells to die. Alzheimer’s disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that affects a person’s ability to function independently.

World Pharma News

Biogen withdraws application for Alzheimer’s disease drug in Europe

Techno -
Biogen Inc. has notified the European Medicines Agency (EMA) of its decision to withdraw its Marketing Authorization Application (MAA) for aducanumab for the treatment...
World Pharma News

US FDA approves donepezil transdermal patch for treatment of Alzheimer disease

Techno -
Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced on Monday the U.S. Food...
World Pharma News

Roche teams up with research institutions for new Alzheimer’s trial

Techno -
Roche announced a new Phase III Alzheimer’s disease prevention trial SKYLINE with gantenerumab, an investigational anti-amyloid antibody that is administered subcutaneously. Roche intends to...
World Pharma News

A simple eye test may identify risk of Alzheimer’s in middle age

Techno -
A simple eye test may make diagnosing the earliest stages of ‘diseases of old age’ possible when people are much younger, University of Otago...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories